Benitec Biopharma EBITDA Margin Growth & History (BNTC)

Benitec Biopharma's ebitda margin was −25,260.00% for fiscal 2023.

View full Benitec Biopharma company overview

Benitec Biopharma annual ebitda margin history

Benitec Biopharma annual ebitda margin

Fiscal yearPeriod endedEBITDA marginChange (percentage points)
20232023-06-30−25,260.00%−1031.23 pp
20222022-06-30−24,228.77%−1576.22 pp
20212021-06-30−22,652.54%−14311.31 pp
20202020-06-30−8,341.24%−8364.97 pp
20192019-06-3023.73%

Benitec Biopharma ebitda margin trends

Between the periods ended 2019-06-30 and 2023-06-30, Benitec Biopharma's ebitda margin decreased from 23.73% to −25,260.00%, a change of −25283.73 percentage points. The latest reported quarter, Q4 2023, shows −64,700.00%.

About the metric

What EBITDA margin means

EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.

Calculation and source

How EBITDA margin is calculated

TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Benitec Biopharma source filings ↗

Community posts

It’s quiet here.

No posts about BNTC yet. Start the conversation.

Write the first post